1 Market Overview
1.1 Parkinsons Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinsons Disease Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Clinical
1.2.3 Experiment
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinsons Disease Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Treament
1.3.3 Prevention
1.4 Global Parkinsons Disease Drugs Market Size & Forecast
1.4.1 Global Parkinsons Disease Drugs Sales in Value (2016-2026))
1.4.2 Global Parkinsons Disease Drugs Sales in Volume (2016-2026)
1.4.3 Global Parkinsons Disease Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Parkinsons Disease Drugs Production Capacity Analysis
1.5.1 Global Parkinsons Disease Drugs Total Production Capacity (2016-2026)
1.5.2 Global Parkinsons Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Parkinsons Disease Drugs Market Drivers
1.6.2 Parkinsons Disease Drugs Market Restraints
1.6.3 Parkinsons Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Parkinsons Disease Drugs Product and Services
2.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Parkinsons Disease Drugs Product and Services
2.2.4 Gilead Sciences Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pacira
2.3.1 Pacira Details
2.3.2 Pacira Major Business
2.3.3 Pacira Parkinsons Disease Drugs Product and Services
2.3.4 Pacira Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Product and Services
2.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Luye Pharma
2.5.1 Luye Pharma Details
2.5.2 Luye Pharma Major Business
2.5.3 Luye Pharma Parkinsons Disease Drugs Product and Services
2.5.4 Luye Pharma Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sigma-Tau Group
2.6.1 Sigma-Tau Group Details
2.6.2 Sigma-Tau Group Major Business
2.6.3 Sigma-Tau Group Parkinsons Disease Drugs Product and Services
2.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Fudan-Zhangjiang
2.7.1 Fudan-Zhangjiang Details
2.7.2 Fudan-Zhangjiang Major Business
2.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Product and Services
2.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business
2.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Product and Services
2.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 CSPC
2.9.1 CSPC Details
2.9.2 CSPC Major Business
2.9.3 CSPC Parkinsons Disease Drugs Product and Services
2.9.4 CSPC Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Parkinsons Disease Drugs Product and Services
2.10.4 Novartis Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Kingond Pharm
2.11.1 Kingond Pharm Details
2.11.2 Kingond Pharm Major Business
2.11.3 Kingond Pharm Parkinsons Disease Drugs Product and Services
2.11.4 Kingond Pharm Parkinsons Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Parkinsons Disease Drugs Sales by Manufacturer
3.1 Global Parkinsons Disease Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Parkinsons Disease Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Parkinsons Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Parkinsons Disease Drugs Manufacturer Market Share
3.4.2 Top 6 Parkinsons Disease Drugs Manufacturer Market Share
3.5 Global Parkinsons Disease Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Parkinsons Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Parkinsons Disease Drugs Market Size by Region
4.1.1 Global Parkinsons Disease Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Parkinsons Disease Drugs Revenue by Region (2016-2026)
4.2 North America Parkinsons Disease Drugs Revenue (2016-2026)
4.3 Europe Parkinsons Disease Drugs Revenue (2016-2026)
4.4 Asia-Pacific Parkinsons Disease Drugs Revenue (2016-2026)
4.5 South America Parkinsons Disease Drugs Revenue (2016-2026)
4.6 Middle East and Africa Parkinsons Disease Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Parkinsons Disease Drugs Sales in Volume by Type (2016-2026)
5.2 Global Parkinsons Disease Drugs Revenue by Type (2016-2026)
5.3 Global Parkinsons Disease Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Parkinsons Disease Drugs Sales in Volume by Application (2016-2026)
6.2 Global Parkinsons Disease Drugs Revenue by Application (2016-2026)
6.3 Global Parkinsons Disease Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Parkinsons Disease Drugs Sales by Type (2016-2026)
7.2 North America Parkinsons Disease Drugs Sales by Application (2016-2026)
7.3 North America Parkinsons Disease Drugs Market Size by Country
7.3.1 North America Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Parkinsons Disease Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Parkinsons Disease Drugs Sales by Type (2016-2026)
8.2 Europe Parkinsons Disease Drugs Sales by Application (2016-2026)
8.3 Europe Parkinsons Disease Drugs Market Size by Country
8.3.1 Europe Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Parkinsons Disease Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Parkinsons Disease Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Parkinsons Disease Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Parkinsons Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Parkinsons Disease Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Parkinsons Disease Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Parkinsons Disease Drugs Sales by Type (2016-2026)
10.2 South America Parkinsons Disease Drugs Sales by Application (2016-2026)
10.3 South America Parkinsons Disease Drugs Market Size by Country
10.3.1 South America Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Parkinsons Disease Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Parkinsons Disease Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Parkinsons Disease Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Parkinsons Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Parkinsons Disease Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Parkinsons Disease Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Parkinsons Disease Drugs Typical Distributors
12.3 Parkinsons Disease Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
【掲載企業】
Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm
【免責事項】
https://www.globalresearch.jp/disclaimer